The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
Public ClinicalTrials.gov record NCT05371756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Texas Immuno-Oncology Biorepository: Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers That Predict Benefit/Resistance to Cancer Therapeutics.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA approved immunotherapeutics across the largest not-for-profit health system in Texas. Comprehensive clinical and radiological data from a diverse population of patients with different racial, social and ethnic backgrounds matched with serial biospecimens over a patients journey with cancer marks the TIOB as a unique research facility.
Study identification
- NCT ID
- NCT05371756
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 10,000 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2020
- Primary completion
- Sep 10, 2035
- Completion
- Sep 10, 2050
- Last update posted
- Mar 15, 2026
2020 – 2050
United States locations
- U.S. sites
- 8
- U.S. states
- 1
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baylor Scott & White Medical Center - College Station | College Station | Texas | 77845 | Recruiting |
| Baylor University Medical Center - Dallas | Dallas | Texas | 75246 | Recruiting |
| Baylor Scott & White All Saints Medical Center - Fort Worth | Fort Worth | Texas | 76104 | Recruiting |
| Baylor Scott & White Medical Center - Plano | Plano | Texas | 75093 | Recruiting |
| Baylor Scott & White Medical Center - Round Rock | Round Rock | Texas | 78665 | Recruiting |
| Baylor Scott & White Medical Center - Temple | Temple | Texas | 76508 | Recruiting |
| Baylor Scott & White Medical Center - Hillcrest | Waco | Texas | 76712 | Recruiting |
| Baylor Scott & White Medical Center - Waxahachie | Waxahachie | Texas | 75165 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05371756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05371756 live on ClinicalTrials.gov.